KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $7.7 million.

  • Twist Bioscience's Other Working Capital Changes rose 300642.57% to $7.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 million, marking a year-over-year increase of 99695.76%. This contributed to the annual value of $3.7 million for FY2025, which is 107303.66% up from last year.
  • As of Q4 2025, Twist Bioscience's Other Working Capital Changes stood at $7.7 million, which was up 300642.57% from $1.9 million recorded in Q3 2025.
  • Twist Bioscience's Other Working Capital Changes' 5-year high stood at $7.7 million during Q4 2025, with a 5-year trough of -$1.1 million in Q1 2025.
  • Its 5-year average for Other Working Capital Changes is $890100.0, with a median of $427500.0 in 2021.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 26811.59% in 2024, then skyrocketed by 300642.57% in 2025.
  • Twist Bioscience's Other Working Capital Changes (Quarter) stood at $91000.0 in 2021, then soared by 1193.41% to $1.2 million in 2022, then fell by 5.18% to $1.1 million in 2023, then plummeted by 77.69% to $249000.0 in 2024, then soared by 3006.43% to $7.7 million in 2025.
  • Its Other Working Capital Changes was $7.7 million in Q4 2025, compared to $1.9 million in Q3 2025 and $2.7 million in Q2 2025.